ArabFinance: Minapharm Pharmaceuticals (Minapharm) posted a standalone net profit of EGP 225.638 million during the first nine months of 2021, compared to EGP 96.09 million in the same period of 2020, the company said in a filing to the Egyptian Exchange.
During the first half of 2021, the company logged consolidated net profit before minority interest of EGP 250.358.
Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products. It is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.